Evidence· July 9, 2026 · 16 min read
Topic
CNS and Migraine
CNS and migraine drug comparisons, payer restrictions, evidence thresholds, and specialty access workflows.
Pipeline· July 1, 2026 · 19 min read
Centanafadine PDUFA July 24, 2026: Pipeline and Access for Otsuka's NDSRI
By Ran Chen#PDUFA Date#Priority Review#CNS and Migraine
Generics· June 26, 2026 · 21 min read
Generic Tecfidera: Dimethyl Fumarate Patent Settlements and NADAC Erosion
By Ran Chen#Generics#Orange Book#PBM
Pricing & Access· May 25, 2026 · 9 min read
CGRP inhibitor access landscape: eight drugs, coverage, and payer criteria in 2026
By Ran Chen#CGRP#CNS and Migraine#Coverage Access